| Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy NG Frangogiannis, O Dewald, Y Xia, G Ren, S Haudek, T Leucker, ... Circulation 115 (5), 584-592, 2007 | 327 | 2007 |
| Inflammation and cardiovascular disease: From mechanisms to therapeutics A Alfaddagh, SS Martin, TM Leucker, ED Michos, MJ Blaha, ... American journal of preventive cardiology 4, 100130, 2020 | 294 | 2020 |
| Coronary heart disease risk: low-density lipoprotein and beyond GE Shaya, TM Leucker, SR Jones, SS Martin, PP Toth Trends in cardiovascular medicine 32 (4), 181-194, 2022 | 166 | 2022 |
| Induction of the CXC chemokine interferon-γ-inducible protein 10 regulates the reparative response following myocardial infarction M Bujak, M Dobaczewski, C Gonzalez-Quesada, Y Xia, T Leucker, ... Circulation research 105 (10), 973-983, 2009 | 157 | 2009 |
| Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling P Zymek, DY Nah, M Bujak, G Ren, A Koerting, T Leucker, P Huebener, ... Cardiovascular research 74 (2), 313-322, 2007 | 105 | 2007 |
| Endothelial–cardiomyocyte crosstalk enhances pharmacological cardioprotection TM Leucker, M Bienengraeber, M Muravyeva, I Baotic, D Weihrauch, ... Journal of molecular and cellular cardiology 51 (5), 803-811, 2011 | 85 | 2011 |
| Effect of evolocumab on atherogenic lipoproteins during the peri-and early postinfarction period: a placebo-controlled, randomized trial TM Leucker, MJ Blaha, SR Jones, MA Vavuranakis, MS Williams, H Lai, ... Circulation 142 (4), 419-421, 2020 | 75 | 2020 |
| Evolocumab, a PCSK9‐monoclonal antibody, rapidly reverses coronary artery endothelial dysfunction in people living with HIV and people with dyslipidemia TM Leucker, G Gerstenblith, M Schär, TT Brown, SR Jones, Y Afework, ... Journal of the American Heart Association 9 (14), e016263, 2020 | 66 | 2020 |
| Chronic Co-Administration of Sepiapterin and l-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 … SL Baumgardt, M Paterson, TM Leucker, J Fang, DX Zhang, ZJ Bosnjak, ... Circulation: Heart Failure 9 (1), e002424, 2016 | 60 | 2016 |
| Cystathionine γ-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6 TM Leucker, Y Nomura, JH Kim, A Bhatta, V Wang, A Wecker, S Jandu, ... American Journal of Physiology-Heart and Circulatory Physiology 312 (4 …, 2017 | 57 | 2017 |
| Coronary endothelial dysfunction is associated with elevated serum PCSK9 Levels in people with HIV independent of low‐density lipoprotein cholesterol TM Leucker, RG Weiss, M Schär, G Bonanno, L Mathews, SR Jones, ... Journal of the American Heart Association 7 (19), e009996, 2018 | 56 | 2018 |
| Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury TM Leucker, ZD Ge, J Procknow, Y Liu, Y Shi, M Bienengraeber, ... PloS one 8 (7), e70088, 2013 | 56 | 2013 |
| Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning N Vladic, ZD Ge, T Leucker, AK Brzezinska, JH Du, Y Shi, DC Warltier, ... American Journal of Physiology-Heart and Circulatory Physiology 301 (5 …, 2011 | 54 | 2011 |
| Contemporary management of dyslipidemia RA Ferraro, T Leucker, SS Martin, M Banach, SR Jones, PP Toth Drugs 82 (5), 559-576, 2022 | 52 | 2022 |
| Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: systematic review and meta-analysis of trials SU Khan, MU Khan, S Valavoor, MS Khan, V Okunrintemi, MA Mamas, ... European journal of preventive cardiology 27 (12), 1255-1268, 2020 | 52 | 2020 |
| Infective endocarditis: beyond the usual tests N Mgbojikwe, SR Jones, TM Leucker, DJ Brotman Cleve Clin J Med 86 (8), 559-567, 2019 | 38 | 2019 |
| Endothelial dysfunction as a nexus for endothelial cell-cardiomyocyte miscommunication TM Leucker, SP Jones Frontiers in Physiology 5, 328, 2014 | 36 | 2014 |
| Sex differences in the age of diagnosis for cardiovascular disease and its risk factors among US adults: trends from 2008 to 2017, the Medical Expenditure Panel Survey V Okunrintemi, M Tibuakuu, SS Virani, LS Sperling, AS Volgman, M Gulati, ... Journal of the American Heart Association 9 (24), e018764, 2020 | 32 | 2020 |
| PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients I Valenta, A Antoniou, W Marashdeh, T Leucker, E Kasper, SR Jones, ... European Heart Journal–Cardiovascular Imaging 18 (5), 538-548, 2017 | 31 | 2017 |
| Effect of crizanlizumab, a P-selectin inhibitor, in COVID-19: a placebo-controlled, randomized trial TM Leucker, WO Osburn, P Reventun, K Smith, B Claggett, BA Kirwan, ... Basic to Translational Science 6 (12), 935-945, 2021 | 29 | 2021 |